U.S. Residential REITs Stock News

Federal National Mortgage Association (FNMA) shares have seen some interesting moves lately, with a steady performance over the past month and a notable 35% gain in the past 3 months. Investors seem to be paying close attention to any signals in the broader mortgage market as they weigh future prospects for FNMA. See our latest analysis for Federal National Mortgage Association. After a phenomenal rally earlier this year, Federal National Mortgage Association’s share price momentum has cooled...

Rubrik (NYSE:RBRK) just expanded its partnership with Cognizant, introducing a new Business Resilience-as-a-Service (BRaaS) solution. This offering is designed to help companies recover quickly from cyberattacks while also enabling safer AI adoption. See our latest analysis for Rubrik. Rubrik’s latest moves with Cognizant and its new Agent Cloud platform have come as momentum in its total shareholder return continues to impress. The return is up nearly 92% over the past year, far outpacing...

If you have been debating what to do with your National Fuel Gas shares, or wondering if now is the right time to buy in, let’s look at what has caught investors’ attention lately. The stock closed at $81.34 yesterday, and while the past week has seen a dip of nearly 6%, National Fuel Gas has still delivered a gain of 32.6% year-to-date and an even more impressive 137.2% over the past five years. That is not the kind of track record you ignore lightly, especially given the choppy energy...

In late October 2025, Kessler Topaz Meltzer & Check, LLP initiated an investigation into CarMax, Inc. for potential federal securities law violations after the company reported significant revenue and profit declines for its fiscal second quarter. This legal review highlights growing investor concerns around the company's recent financial disclosures and overall corporate governance amid a challenging period. We'll now explore how the federal securities investigation, prompted by recent...

Organon (OGN) is undergoing a major leadership transition after CEO Kevin Ali resigned following an internal audit that revealed issues with wholesaler sales practices for its Nexplanon product. The Board quickly named Joseph Morrissey as Interim CEO and outlined steps to improve oversight. See our latest analysis for Organon. Organon's leadership shakeup and the internal audit have clearly rattled investors, with the share price down over 50% year-to-date and the 1-year total shareholder...

If you have been eyeing Danaher stock lately and wondering what to do next, you are certainly not alone. It is one of those names that frequently finds itself at the center of investor debates, especially after sharp price swings. Over the last month, Danaher has bounced back with an impressive 19.6% gain, recouping much of the ground lost earlier this year. In a shorter timeframe, just in the past week, the stock is up another 6.1%. Despite those recent gains, the year-to-date total return...

ASP Isotopes Inc. recently completed a follow-on equity offering, raising approximately US$210.3 million through the sale of over 17 million shares of common stock at US$12.25 per share, following a series of significant business updates including a major silicon-28 supply agreement and a US radiopharmacy acquisition. This combination of capital raise and operational expansion signals the company's focus on scaling its advanced materials and radiopharmaceutical operations with biotech assets...

Carter's (CRI) reported a net profit margin of 4.7%, down from 8.1% a year ago, and annual earnings have declined by 6.8% over the past five years. Revenue is set to decrease by 1.1% per year over the next three years, while recent earnings growth remains negative. With the stock trading at a Price-To-Earnings ratio of 9.1x, notably lower than the industry average, investors are weighing the value case against ongoing pressure on margins and profits. See our full analysis for Carter's. Next,...

Maximus (MMS) shares have edged lower over the past month, down about 2%, even as the company continues to post steady annual revenue and profit growth. Investors are weighing these moves against strong multi-year returns. See our latest analysis for Maximus. Maximus’s 1-year total shareholder return sits at just under 1%, yet the 20% share price gain over the past 90 days has turned some heads after a quieter start to the year. Momentum is building as long-term holders have seen a robust 46%...

In the past week, The Hershey Company secured a new five-year unsecured revolving credit facility of up to US$1.88 billion and was the subject of positive analyst upgrades, coinciding with reports of record Halloween candy spending despite higher prices. Amid persistent cost pressures from elevated cocoa prices, Hershey's improving analyst sentiment highlights how industry trends and seasonal demand can shift investor outlooks even in challenging market conditions. We’ll examine how renewed...

Intuit (INTU) just announced a new partnership with Aprio, combining its AI-powered ERP solution with Aprio's business advisory services to help mid-market firms manage their operations more efficiently and scale with fewer technology headaches. See our latest analysis for Intuit. Intuit’s partnership with Aprio comes at an interesting moment for shareholders. While short-term momentum has cooled, with a 15.25% drop in the 90-day share price return, the story over the past year is still...

Earlier this week, Super Micro Computer, Inc. reported preliminary first-quarter fiscal 2026 revenue of US$5 billion, significantly below expectations due to delayed deployments for large artificial intelligence projects, but reaffirmed its full-year revenue guidance of at least US$33 billion on the basis of over US$12 billion in newly secured business and continued AI infrastructure demand. An important insight is that while first-quarter sales were deferred rather than lost, Super Micro's...

East West Bancorp (EWBC) just posted record results for the third quarter of 2025, highlighting historic highs across revenue, net income, earnings per share, and deposits. This momentum came from healthy deposit-led loan growth as well as strong fee businesses. See our latest analysis for East West Bancorp. East West Bancorp’s momentum has been mirrored in its stock performance, with a solid 8.8% share price return year-to-date and a remarkable 211% total shareholder return over the past...

Gorman-Rupp (GRC) released its third-quarter 2025 results, reporting revenue and earnings that came in below expectations. The company’s stock reacted to weaker profitability, as gross margin trended lower for the quarter. See our latest analysis for Gorman-Rupp. Gorman-Rupp’s share price pulled back after its latest earnings miss, but the bigger story is the strong underlying momentum. This year’s 24.2% gain in share price, capped by a 25.8% total shareholder return over twelve months, shows...

Sensata Technologies Holding (ST) shares have climbed about 5% over the past month. Investors are watching closely to see if this momentum can be sustained, especially as the company continues to navigate a competitive sector. See our latest analysis for Sensata Technologies Holding. After a strong 1-month share price return of 4.6%, Sensata Technologies Holding is showing some renewed momentum compared to earlier periods. While the stock has logged a 16% gain so far this year, the...

If you're sizing up Bank of America and wondering if now is the right time to jump in, you're definitely not alone. Fresh off a strong stretch, the stock has notched an impressive 1.9% gain over the past week and climbed 1.6% over the last month. The real eyebrow-raiser, though, is its long-term trajectory, up nearly 20% year-to-date and an eye-popping 148.7% over the last five years. Clearly, there is momentum behind the ticker, and much of that can be traced to investor confidence in the...

Hims & Hers Health (HIMS) just revealed a new specialty centered on menopause and perimenopause, designed around the specific health needs and preferences of women navigating these life stages. This move expands the company’s reach and highlights its commitment to personalized care and platform innovation. See our latest analysis for Hims & Hers Health. Hims & Hers Health is catching eyes with its innovative expansion, but lately the stock has seen a sharp pullback. Its 1-month share price...

Bristol-Myers Squibb (BMY) shares have seen a drop of 1% over the past day, with the stock struggling to regain ground from one month to the next. Investors continue to watch for signs of a turnaround. See our latest analysis for Bristol-Myers Squibb. Despite recent turbulence, Bristol-Myers Squibb’s share price has trended lower over the past year. Longer-term total shareholder return is also firmly in the red as market sentiment has cooled and risk perceptions have shifted. Short-term...

Stellar Bancorp (STEL) released its third quarter earnings, showing results that largely matched what analysts were expecting. A steady net interest margin and strong deposit growth helped reinforce the company’s balance sheet, despite some lingering headwinds. See our latest analysis for Stellar Bancorp. Stellar Bancorp’s balance sheet momentum in the third quarter is showing up in the stock’s performance as well. While the 1-year total shareholder return sits at 9.5%, the share price has...

In September, Mercury Systems, Inc. announced it was awarded a multi-year, cost-plus-fixed-fee contract to develop a multi-mission, multi-domain subsystem for a leading U.S. defense prime contractor, utilizing its Processing Platform technology. This contract award highlights the defense industry's trust in Mercury's ability to deliver advanced, integrated solutions that can be scaled for critical national security applications. We'll examine how this major contract win could influence...

uniQure (NasdaqGS:QURE) just released data showing that its AMT-130 gene therapy can actually impact the progression of Huntington’s disease, which is catching the attention of investors across the biotech sector. See our latest analysis for uniQure. uniQure’s breakthrough with AMT-130 has sparked renewed optimism, sending its share price up 11% in just one day and an incredible 25% over the past month. Momentum has been building all year, with a year-to-date share price return of 276%. For...

Jamf Holding (JAMF) has introduced a new AI-powered capability designed to simplify and accelerate mobile forensic analysis for security teams. Announced during its annual user conference, this development targets organizations that are seeking faster and more accessible threat response tools. See our latest analysis for Jamf Holding. Recent weeks have seen Jamf Holding in the spotlight for its new AI-driven threat analysis solution. Despite this innovation, Jamf’s share price return remains...

Century Communities (CCS) just wrapped up their third quarter, reporting revenue that topped forecasts and delivering 2,486 homes, which met the upper range of their guidance. Investors are paying close attention as the company also achieved a slight improvement in homebuilding gross margins and managed to refinance its senior notes at a lower interest rate. See our latest analysis for Century Communities. Despite cautious guidance and some normalization in earnings, Century Communities has...

Coca-Cola FEMSA (NYSE:KOF) surpassed expectations in its third quarter, delivering higher earnings and revenue. The company managed this growth by improving expense efficiencies and benefiting from gains related to foreign exchange movements. See our latest analysis for Coca-Cola FEMSA. de. That strong third quarter report gave Coca-Cola FEMSA’s shares another nudge higher, with a seven-day share price return of 4.68% and a year-to-date gain of 13.34%. Total shareholder returns tell much the...